Imaging of Cerebral Amyloid Angiopathy (CAA) using syngo SWI
Markus Lentschig, M.D.
MR, Nuclear Medicine and PET/CT Center Bremen Mitte, Bremen, Germany | Jun 15, 2010
Compared to conventional T2*-weighted imaging susceptibility-weighted imaging (syngo SWI) is very sensitive in detection of small bleedings and small vascular malformations. In his case report Markus Lentschig, M.D. from the MR Center Bremen in Germany shows that syngo SWI is also a sensitive tool for the precise assessment of cerebral amyloid angiopathy (CAA). Multiple smallest cortical and subcortical bleedings were depicted in detail and in this case extend and severity of CAA as visualized by SWI would have been clearly underestimated based on conventional MRI only.
The information presented is for illustration only and is not intended to be relied upon by the reader for instruction as to the practice of medicine. Any health care practitioner reading this information is reminded that they must use their own learning, training and expertise in dealing with their individual patients. This material does not substitute for that duty and is not intended by Siemens Healthcare to be used for any purpose in that regard.
The drugs and doses mentioned herein are consistent with the approval labelling for uses and/or indications of the drug. The treating physician bears the sole responsibility for the diagnosis and treatment of patients, including drugs and doses prescribed in connection with such use. The Operating Instructions must always be strictly followed when operating the system. The source for the technical data is the corresponding data sheets. Results may vary.